Article

Barbotage cytology gives way to biopsy

Ann Arbor, MI-Urologists should use biopsy, not barbotage cytology, to assess tumors and select treatment for upper-tract urothelial carcinomas, advise researchers at the University of Michigan Urology Center in Ann Arbor.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Subscribe Now!
Related Videos
Rana McKay, MD, outlines key findings from the phase 2 COMRADE trial
Rana McKay, MD, outlines key findings from the phase 2 COMRADE trial
Rian J. Dickstein, MD, answers a question during a Zoom video interview
Phase 2 data highlight potential of detalimogene voraplasmid
4 experts in this video
Early Recurrent Low-Grade, Intermediate-Risk NMIBC
Related Content
Survey data shows lack of awareness on prostate, testicular cancer
August 29th 2025

Survey data shows lack of awareness on prostate, testicular cancer

Hannah Clarke
Pearls & Perspectives: Treating Male Pelvic Floor Dysfunction, with Adam Gvili, PT, DPT
August 29th 2025

Pearls & Perspectives: Treating Male Pelvic Floor Dysfunction, with Adam Gvili, PT, DPT

Amy M. Pearlman, MD
Decipher test is predictive of chemotherapy benefit in metastatic prostate cancer
August 29th 2025

Decipher test is predictive of chemotherapy benefit in metastatic prostate cancer

Hannah Clarke
First Assist: The Historical Context of Advanced Kidney Cancer, with Eric A. Singer, MD
August 29th 2025

First Assist: The Historical Context of Advanced Kidney Cancer, with Eric A. Singer, MD

Taylor Goodstein, MD
AI tool can detect prostate cancer missed by pathologists
August 29th 2025

AI tool can detect prostate cancer missed by pathologists

Hannah Clarke
Ongoing clinical trials and emerging agents in BCG-unresponsive NMIBC
August 29th 2025

Ongoing clinical trials and emerging agents in BCG-unresponsive NMIBC

Hannah Clarke
© 2025 MJH Life Sciences

All rights reserved.